임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 중· Upper Limb Essential TremorStudy of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
리드: 애브비
- 2상모집 중· Chronic Lymphocytic Leukemia (CLL)Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
리드: 아스트라제네카 · 협력: 애브비, 로슈
- 2상모집 중· Lung Non-Small Cell CarcinomaTelisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer
협력: 애브비
- 2상모집 중· Idiopathic Pulmonary FibrosisStudy of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
리드: 애브비
- 2상모집 중· Major Depressive DisorderA Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
리드: 애브비
- 2상모집 중· Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients
협력: 애브비
- 2상모집 중· Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy
협력: 애브비
- 2상모집 중· Small Cell Lung CancerA Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
리드: 애브비
- 2상모집 중· Epithelial Ovarian CancerA Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
리드: 애브비
- 2상모집 중· Waldenstrom MacroglobulinemiaA Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
협력: 애브비, 일라이 릴리
- 2상모집 예정· Aggressive Diffuse Large B-cell LymphomaCombining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
협력: 애브비
- 2상모집 중· Marginal Zone LymphomaEpcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)
협력: 애브비
- 2상모집 중· Bipolar I or II DisorderStudy to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
리드: 애브비
- 2상모집 중· Primary CNS Lymphoma (PCNSL)Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab
협력: 애브비
- 2상모집 중· Intensive Chemotherapy UnfitAlternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
협력: 애브비
- 2상모집 중· Rheumatoid ArthritisA Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
리드: 애브비
- 2상모집 중· Advanced High-Grade Epithelial Ovarian CancerA Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
리드: 애브비
- 2상모집 중· Generalized Anxiety Disorder (GAD)Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
리드: 애브비
- 2상모집 중· Psoriatic ArthritisStudy of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
리드: 애브비
- 2상모집 중· Waldenstrom MacroglobulinemiaEfficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia
협력: 애브비, 화이자
- 2상모집 중단 (진행 중)· Mantle Cell LymphomaGATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma
협력: 애브비, 일라이 릴리, 로슈
- 2상모집 중· T-cell Acute Lymphoblastic LeukemiaAdding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
협력: 애브비
- 2상모집 중· Locally Advanced Unresectable or Metastatic Gastric AdenocarcinomaA Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
리드: 애브비
- 2상모집 중· Relapsed or Refractory Acute Myeloid Leukemia (AML)BCL2i CLAG-M in R/R Acute Myeloid Leukemia
협력: 애브비
- 2상모집 중· Acute Myeloid LeukemiaDiscontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
협력: 애브비
- 2상모집 중· Gram-negative Bacterial InfectionA Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
리드: 화이자 · 협력: 애브비
- 2상모집 중· Relapsed/Refractory Large B-cell LymphomaMRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma
협력: 애브비
- 2상모집 중· Acute Myeloid LeukemiaVenetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
협력: 애브비
- 2상모집 중단 (진행 중)· Unresectable Metastatic Colorectal CancerStudy to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab
리드: 애브비
- 2상모집 중단 (진행 중)· Chronic Myeloid LeukemiaAzacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)
협력: 애브비
- 2상모집 중· Ovary CancerAn Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
협력: 애브비
- 2상모집 중단 (진행 중)· Chronic Myeloid LeukemiaVenetoclax After TKI to Target Persisting Stem Cells in CML
협력: 애브비
- 2상모집 중단 (진행 중)· Acute Myeloid Leukemia (AML)Venetoclax in Combination With 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy
협력: 애브비
- 2상모집 중단 (진행 중)· High Grade Ovarian CancerMirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
리드: 애브비
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.